Consultation Launched on Proposed Changes to the ABPI Code of Practice for the Pharmaceutical Industry?
![](/46/pdcnewsitem/03/35/05/Iorsqjh1Cc8XErH.jpg)
Consultation launched on proposed changes to the ABPI Code of Practice for the Pharmaceutical Industry and the Constitution and Procedure for the Prescription Medicines Code of Practice Authority
Changes are proposed to the 2014 ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure.
There are a number of reasons for the changes including the work done by the group established by the ABPI Board to review the Code. Additional changes are also needed to implement fully the European Federation of Pharmaceutical Industry Associations (EFPIA) Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations.
Updates to the EFPIA Disclosure Code and the EFPIA Code on the Promotion of Prescription-Only Medicines to, and Interactions with, Healthcare Professionals were agreed at the EFPIA General Assembly on 6 June 2014. The Medicines and Healthcare Products Regulatory Agency (MHRA) consultation as part of the red tape challenge and the regular update of the Code and its operation have also resulted in proposals.
Key proposals relate to changes around transparency and disclosure of some payments to health professionals including the creation of a central platform for disclosure, updates to certification requirements for Joint Working and the proposed introduction of a Product Related Service Provison.
The attached documents set out proposals to amend the ABPI Code and the Constitution and Procedure.
1. Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry
2. Proposals to amend the PMCPA Constitution and Procedure
6. Draft template (UK amendments to EFPIA version).
The timetable is as follows:
Friday, 11 July
Proposals sent to ABPI members, non members that have agreed to comply with the Code and those organisations cited in the PMCPA Constitution and Procedure. Proposals put on the PMCPA website for public consultation.
Friday, 5 September
Consultation closes.
Tuesday, 7 October
Final proposals to be agreed by the ABPI Board of Management.
Thursday, 20 November
Proposals to be before the ABPI Half-Yearly General Meeting.
Thursday, 1 January 2015
New Code to come into operation.
Related News
-
News Global advancements in the diagnosis and treatment of rare diseases: Rare Disease Day 2024
Rare Diseases Day is celebrated on the 29th February 2024 and represents the plight of rare disease patients to gain diagnosis and access to suitable treatment. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance